Wilhite AM - Search Results

1

Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.

Wilhite AM, Oestreich MC, Olson M, Bedell SM, Westenberg D, Bangdiwala A, Ikramuddin S, Sanchez-Avila M, Madoff RD, Khalifa MA, Erickson BK. Wilhite AM, et al. Obstet Gynecol. 2019 Sep;134(3):520-526. doi: 10.1097/AOG.0000000000003421. Obstet Gynecol. 2019. PMID: 31403600 Free PMC article.

2

Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.

Bedell SM, Hedberg C, Griffin A, Pearson H, Wilhite A, Rubin N, Erickson BK. Bedell SM, et al. Gynecol Oncol. 2019 Aug;154(2):276-279. doi: 10.1016/j.ygyno.2019.05.028. Epub 2019 Jun 3. Gynecol Oncol. 2019. PMID: 31171409 Free PMC article.

3

Successful robotic surgery for primary resection of a vaginal leiomyosarcoma: A case report.

Hagen J, Wilhite A, Tarbunova M, Erickson B. Hagen J, et al. Gynecol Oncol Rep. 2019 Oct 4;30:100503. doi: 10.1016/j.gore.2019.100503. eCollection 2019 Nov. Gynecol Oncol Rep. 2019. PMID: 31656851 Free PMC article.

4

Molecular profiles of endometrial cancer tumors among Black patients.

Wilhite AM, Baca Y, Xiu J, Paladugu R, ElNaggar AC, Brown J, Winer IS, Morris R, Erickson BK, Olawaiye AB, Powell M, Korn WM, Rocconi RP, Khabele D, Jones NL. Wilhite AM, et al. Gynecol Oncol. 2022 Jul;166(1):108-116. doi: 10.1016/j.ygyno.2022.04.014. Epub 2022 Apr 28. Gynecol Oncol. 2022. PMID: 35490034

5

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy.

Klc TR, Wu S, Wilhite AM, Jones NL, Powell MA, Olawaiye A, Girda E, Brown J, Puechl A, Ali-Fehmi R, Winer IS, Herzog TJ, Korn WM, Erickson BK. Klc TR, et al. Among authors: wilhite am. Gynecol Oncol. 2022 Nov;167(2):289-294. doi: 10.1016/j.ygyno.2022.09.006. Epub 2022 Sep 14. Gynecol Oncol. 2022. PMID: 36114027

6

A novel proteomic-based screening method for ovarian cancer using cervicovaginal fluids: A window into the abdomen.

Rocconi RP, Wilhite AM, Schambeau L, Scalici J, Pannell L, Finan MA. Rocconi RP, et al. Among authors: wilhite am. Gynecol Oncol. 2022 Jan;164(1):181-186. doi: 10.1016/j.ygyno.2021.10.083. Epub 2021 Oct 30. Gynecol Oncol. 2022. PMID: 34756750

7

Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management.

Khan MA, Vikramdeo KS, Sudan SK, Singh S, Wilhite A, Dasgupta S, Rocconi RP, Singh AP. Khan MA, et al. Semin Cancer Biol. 2021 Dec;77:99-109. doi: 10.1016/j.semcancer.2021.08.005. Epub 2021 Aug 18. Semin Cancer Biol. 2021. PMID: 34418576 Free PMC article. Review.

8

Perivascular epithelioid cell tumor (PEComa) of the uterus: Challenges of pregnancy in determining prognosis and optimal treatment.

Wilhite AM, Dal Zotto V, Pettus P, Jeansonne J, Scalici J. Wilhite AM, et al. Gynecol Oncol Rep. 2022 Mar 21;40:100962. doi: 10.1016/j.gore.2022.100962. eCollection 2022 Apr. Gynecol Oncol Rep. 2022. PMID: 35341106 Free PMC article.

9

Transforming growth factor beta in bovine placentas.

Munson L, Wilhite A, Boltz VF, Wilkinson JE. Munson L, et al. Biol Reprod. 1996 Oct;55(4):748-55. doi: 10.1095/biolreprod55.4.748. Biol Reprod. 1996. PMID: 8879485

10

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer.

Borneman RM, Gavin E, Musiyenko A, Richter W, Lee KJ, Crossman DK, Andrews JF, Wilhite AM, McClellan S, Aragon I, Ward AB, Chen X, Keeton AB, Berry K, Piazza GA, Scalici JM, da Silva LM. Borneman RM, et al. Among authors: wilhite am. J Ovarian Res. 2022 Nov 2;15(1):120. doi: 10.1186/s13048-022-01050-9. J Ovarian Res. 2022. PMID: 36324187 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page